Annovis Bio, Inc. (ANVS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.53M | +85.1% |
| 2024 | $10.55M | +83.4% |
| 2023 | $5.75M | -79.7% |
| 2022 | $28.38M | -37.9% |
| 2021 | $45.69M | +465.8% |
| 2020 | $8.07M | +434488.7% |
| 2019 | $1.9K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.53M | +85.1% |
| 2024 | $10.55M | +83.4% |
| 2023 | $5.75M | -79.7% |
| 2022 | $28.38M | -37.9% |
| 2021 | $45.69M | +465.8% |
| 2020 | $8.07M | +434488.7% |
| 2019 | $1.9K | — |